Abstract
Novel quinazoline derivatives have been designed, synthesized and tested for cytotoxic activity against HCT116, and MCF-7 cell lines. The preliminary data indicate their promising antitumor potential. Enzyme inhibitory activity of the most active product against VEGFR-2 has been assessed. Apoptosis and cell cycle arrest during the G2/M phase has been triggered by the product, and according to the gene expression data, it increases BAX and caspase-3 expression while decreasing Bcl-2 expression.
Similar content being viewed by others
REFERENCES
Kasibhatla, S., Baichwal, V., Cai, S.X., Roth, B., Skvortsva, I., Skvortsov, S., Lucas, P., English, N.M., Sirisoma, N., Drewe, J., Pervin, A., Tseng, B., Carlson, R.O., and Pleiman, C.M., Cancer Res., 2007, vol. 67, pp. 5865–5871. https://doi.org/10.1016/j.ejmech.2011.10.056
Ahmed, M.F. and Belal, A., Res. Chem. Intermed., 2016, vol. 42, pp. 659–671. https://doi.org/10.1007/s11164-015-2048-8
Ahmed, M.F., Belal, A., and Youns, M., Med. Chem. Res., 2015, vol. 24, pp. 2993–3007. https://doi.org/10.1007/s00044-015-1357-1
Ahmed, M.F. and Hashim, A.A.A., Res. Chem. Intermed., 2016, vol. 42 (3), pp. 1777–1789. https://doi.org/10.1007/s11164-015-2117-z
Ahmed, M.F. and Belal, A., Arch. Pharm. Chem. Life Sci., 2015, vol. 348, pp. 487–497. https://doi.org/10.1002/ardp.201400468
Alagarsamy, V., Solomon, V.R., Sheorey, R.V., and Jayakumar, R., Chem. Biol. Drug Des., 2009, vol. 73, pp. 471–479. https://doi.org/10.1134/S1068162021010246
Smits, R.A., Adami, M., Istyastono, E.P., Zuiderveld, O.P., van Dam, C.M.E., de Kanter, F.J.J., Jongejan, A., Coruzzi, G., Leurs, R., and de Esch, I.J., J. Med. Chem., 2010, vol. 53, pp. 2390–2400. https://doi.org/10.1021/jm901379s
Held, F.E., Guryev, A.A., Fröhlich, T., Hampel, F., Kahnt, A., Hutterer, C., Steingruber, M., Bahsi, H., von Bojničić-Kninski, C., Mattes, D.S., and Foertsch, T.C., Nature Commun., 2017, vol. 8(1), pp. 1–9. https://doi.org/10.1038/ncomms15071
Raghavendra, N.M., Thampi, P., Gurubasavarajaswamy, P.M., and Sriram, D., Chem. Pharm. Bull., 2007, vol. 55, pp. 1615–1619. https://doi.org/10.1248/cpb.55.1615
Bugge, S., Kaspersen, S.J., Larsen, S., Nonstad, U., Bjørkøy, G., Sundby, E., and Hoff, B.H., Eur. J. Med. Chem., 2014, vol. 75, pp. 354–374. https://doi.org/10.1016/j.ejmech.2014.01.042
El‐Helby, A.G.A., Sakr, H., Eissa, I.H., Abulkhair, H., Al‐Karmalawy, A.A., and El‐Adl, K., Archiv der Pharmazie, 2019, vol. 352(10), p. 1900113. https://doi.org/10.1002/ardp.201900113
Goodman, V.L., Rock, E.P., Dagher, R., Ramchandani, R.P., Abraham, S., Gobburu, J.V., Booth, B.P., Verbois, S.L., Morse, D.E., Liang, C.Y., and Chidambaram, N., Clin. Cancer Res., 2007, vol. 13, pp. 1367–73. https://doi.org
Fallah, A., Sadeghinia, A., Kahroba, H., Samadi, A., Heidari, H.R., Bradaran, B., Zeinali, S., and Molavi, O., Biomed. Pharmacother., 2019, vol. 110, pp. 775–785. https://doi.org/10.1016/j.biopha.2018.12.022
Peng, F.W., Liu, D.K., Zhang, Q.W., Xu, Y.G., and Shi, L., Expert Opin. Ther. Pat., 2017, vol. 27 (9), pp. 987–1004. https://doi.org/10.1080/13543776.2017.1344215
Al-Salem, H.S., Hegazy, G.H., El-Taher, K.E., El-Messery, S.M., Al-Obaid, A.M., and El-Subbagh, H.I., Bioorg. Med. Chem. Lett., 2015, vol. 25(7), pp. 1490–1499. https://doi.org/10.1016/j.bmcl.2015.02.025
Gürsoy, A. and Karalı, N., Eur. J. Med. Chem., 2003, vol. 38(6), pp. 633–643. https://doi.org/10.1016/S0223-5234(03)00085-0
Eldehna, W.M., El Hassab, M.A., Abo-Ashour, M.F., Al-Warhi, T., Elaasser, M.M., Safwat, N.A., Suliman, H., Ahmed, M.F., Al-Rashood, S.T., Abdel-Aziz, H.A., and El-Haggar, R., Bioorg. Chem., 2021, vol. 110, p. 104748. https://doi.org/10.1016/j.bioorg.2021.104748
Ahmed, M.F. and Santali, E.Y., Bioorg. Chem., 2021, vol. 111, p. 104842. https://doi.org/10.1016/j.bioorg.2021.104842
Parida, P.K., Mahata, B., Santra, A., Chakraborty, S., Ghosh, Z., Raha, S., Misra, A.K., Biswas, K., Jana, K., Cell Death Dis., 2018, vol. 9(5), pp. 1–18. https://doi.org/10.1038/s41419-018-0476-2
Kim, K.H. and Sederstrom, J.M., Curr. Protocol. Mol. Biol., 2015, vol. 111(1), p. 28. https://doi.org/10.1002/0471142727.mb2806s111
Vermes, I., Haanen, C., Steffens-Nakken, H., and Reutellingsperger, C., J. Immunolog. Methods, 1995, vol. 184, pp. 39–51. https://doi.org/10.1016/0022-1759(95)00072-I
Abdel-Rahman, I.M., Mustafa, M., Mohamed, S.A., Yahia, R., Abdel-Aziz, M., Abuo-Rahma, G.E.D.A., and Hayallah, A.M., Bioorg. Chem., 2021, vol. 107, p. 104629. https://doi.org/10.1016/j.bioorg.2021.104629
ACKNOWLEDGMENTS
The authors are grateful to Taif University Researchers Supporting Project number (TURSP-2020/123), Taif University, Taif, Saudi Arabia, for their support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
No conflict of interest was declared by the authors.
Rights and permissions
About this article
Cite this article
Ahmed, M.F., Khalifa, A.S. & Eed, E.M. Design, Synthesis, Anticancer Activity, and Cell Cycle Analysis of Novel Quinazoline Derivatives Targeting VEGFR-2 Kinase. Russ J Gen Chem 91, 2497–2505 (2021). https://doi.org/10.1134/S1070363221120203
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1070363221120203